| Interactions between Microbiome and DME (MICBIO)
|
| Bacteria: Bacteroidetes |
| Bacteroides fragilis (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sumatriptan succinate |
Click to Show/Hide the Detail |
| Drug ID |
DR1517
Drug Info
|
| Interaction Mechanism |
Human Monoamine oxidase type A (MAO-A) and Bacteroides fragilis co-metabolize the drug Sumatriptan succinate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Bacteroides thetaiotaomicron (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Sumatriptan succinate |
Click to Show/Hide the Detail |
| Drug ID |
DR1517
Drug Info
|
| Interaction Mechanism |
Human Monoamine oxidase type A (MAO-A) and Bacteroides thetaiotaomicron co-metabolize the drug Sumatriptan succinate, which can collectively affect efficacy, safety or bioavailability of this drug. |
[1], [2] |
| Odoribacter laneus (CFB bacteria) |
Click to Show/Hide the Full List of Drugs: 1 Drugs Metabolized
|
| Epinephrine hydrochloride |
Click to Show/Hide the Detail |
| Drug ID |
DR0590
Drug Info
|
| Interaction Mechanism |
Human Monoamine oxidase type A (MAO-A) and Odoribacter laneus co-metabolize the drug Epinephrine hydrochloride, which can collectively affect efficacy, safety or bioavailability of this drug. |
[3], [4] |
|
|
|
|
|
|